U.S. FDA advisers back Moderna COVID booster shots for older and high-risk people

13 Sept 14:12 Key points summarised by AI

FDA Advisers Endorse Moderna Boosters: A U.S. FDA advisory panel unanimously recommended Moderna's COVID-19 booster shots for individuals aged 65 and older, those at high risk of severe illness, and those with occupational exposure.
Path to Implementation: The recommendation now moves to the FDA for final approval, followed by specific guidelines from the U.S. Centers for Disease Control and Prevention (CDC) on who should receive the shots.
Booster Specifics and Rationale: Moderna's booster contains a 50-microgram dose, half the original, to be administered at least six months after the initial two-shot series, with advisers noting increased protective antibodies and positive real-world data from Israel's booster program.

Sihasak urges Thais in Europe to stay alert as protests spread

Yesterday 12:06 Key points summarised by AI

Thai Foreign Minister Sihasak Phuangketkeow advises Thai nationals in Europe to avoid protest areas and reconsider non-essential travel, citing widespread unrest in countries like France, Italy, and Spain.
The warning comes as demonstrations escalate, with some turning violent, prompting concerns for safety and leading to an emergency Cabinet meeting in Italy and a proposed postponement of diplomatic talks.
Thai embassies and the Department of Consular Affairs issue advisories, urging citizens to monitor local developments, follow official announcements, and register their travel details for assistance, while emphasizing that no Thais have been directly affected yet.